
Robert Gerstl
Examiner (ID: 15570)
| Most Active Art Unit | 1202 |
| Art Unit(s) | 1205, 1206, 1202, 1613, 1803, 1614, 1201, 1626 |
| Total Applications | 3154 |
| Issued Applications | 2456 |
| Pending Applications | 123 |
| Abandoned Applications | 575 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18418360
[patent_doc_number] => 20230172818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => MULTI-PHASE ORAL COMPOSITION FOR TOOTH WHITENING
[patent_app_type] => utility
[patent_app_number] => 17/503553
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503553
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503553 | Multi-phase oral composition for tooth whitening | Oct 17, 2021 | Issued |
Array
(
[id] => 18808486
[patent_doc_number] => 20230382819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => PROCESSES FOR SYNTHESIS OF ALPHA-EMITTING RADIOPHARMACEUTICALS
[patent_app_type] => utility
[patent_app_number] => 18/031760
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17369
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18031760
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/031760 | PROCESSES FOR SYNTHESIS OF ALPHA-EMITTING RADIOPHARMACEUTICALS | Oct 13, 2021 | Pending |
Array
(
[id] => 18879042
[patent_doc_number] => 20240002411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => METHOD FOR PRODUCING RADIOACTIVE ZIRCONIUM COMPLEX
[patent_app_type] => utility
[patent_app_number] => 18/249837
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18249837
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/249837 | METHOD FOR PRODUCING RADIOACTIVE ZIRCONIUM COMPLEX | Oct 13, 2021 | Pending |
Array
(
[id] => 19246941
[patent_doc_number] => 20240197925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => FUNCTIONALIZED DIBLOCK COPOLYMER AND ITS PREPARATION METHOD AND APPLICATION
[patent_app_type] => utility
[patent_app_number] => 18/028218
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18028218
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/028218 | FUNCTIONALIZED DIBLOCK COPOLYMER AND ITS PREPARATION METHOD AND APPLICATION | Sep 23, 2021 | Pending |
Array
(
[id] => 17458619
[patent_doc_number] => 20220071923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF PEROXISOMAL DISORDERS AND LEUKODYSTROPHIES
[patent_app_type] => utility
[patent_app_number] => 17/479400
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479400
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479400 | COMPOSITIONS AND METHODS FOR TREATMENT OF PEROXISOMAL DISORDERS AND LEUKODYSTROPHIES | Sep 19, 2021 | Abandoned |
Array
(
[id] => 17774837
[patent_doc_number] => 20220241186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF BUPRENORPHINE
[patent_app_type] => utility
[patent_app_number] => 17/472502
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472502
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472502 | IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF BUPRENORPHINE | Sep 9, 2021 | Abandoned |
Array
(
[id] => 17297798
[patent_doc_number] => 20210393637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => CANCER TREATMENTS USING COMBINATIONS OF CDK AND ERK INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/460743
[patent_app_country] => US
[patent_app_date] => 2021-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17460743
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/460743 | Cancer treatments using combinations of CDK and ERK inhibitors | Aug 29, 2021 | Issued |
Array
(
[id] => 20438631
[patent_doc_number] => 12509458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => [
[patent_app_type] => utility
[patent_app_number] => 18/022192
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 992
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022192
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022192 | [ | Aug 19, 2021 | Issued |
Array
(
[id] => 17412815
[patent_doc_number] => 20220047719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => ENHANCING SUBCUTANEOUS INJECTION AND TARGET TISSUE ACCUMULATION OF NANOPARTICLES VIA CO-ADMINISTRATION WITH MACROPINOCYTOSIS INHIBITORY NANOPARTICLES (MINP)
[patent_app_type] => utility
[patent_app_number] => 17/445285
[patent_app_country] => US
[patent_app_date] => 2021-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445285
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/445285 | ENHANCING SUBCUTANEOUS INJECTION AND TARGET TISSUE ACCUMULATION OF NANOPARTICLES VIA CO-ADMINISTRATION WITH MACROPINOCYTOSIS INHIBITORY NANOPARTICLES (MINP) | Aug 16, 2021 | Pending |
Array
(
[id] => 17272733
[patent_doc_number] => 20210378931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => COSMETIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/403157
[patent_app_country] => US
[patent_app_date] => 2021-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17403157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/403157 | COSMETIC COMPOSITIONS | Aug 15, 2021 | Pending |
Array
(
[id] => 19331381
[patent_doc_number] => 20240245811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => ALPHA RADIOLABELED GASTRIN ANALOGUE AND USE THEREOF IN METHODS OF TREATING CCKB RECEPTOR POSITIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/040021
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040021
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040021 | ALPHA RADIOLABELED GASTRIN ANALOGUE AND USE THEREOF IN METHODS OF TREATING CCKB RECEPTOR POSITIVE DISEASES | Jul 29, 2021 | Pending |
Array
(
[id] => 18829588
[patent_doc_number] => 20230398112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => SPRAY-DRIED METAL-ORGANIC FRAMEWORKS FOR TREATMENT AND/OR DIAGNOSIS OF PULMONARY DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/020687
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020687
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/020687 | SPRAY-DRIED METAL-ORGANIC FRAMEWORKS FOR TREATMENT AND/OR DIAGNOSIS OF PULMONARY DISEASE | Jul 29, 2021 | Pending |
Array
(
[id] => 18581661
[patent_doc_number] => 20230263915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => RADIOLABELED COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/007002
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007002
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007002 | RADIOLABELED COMPOUNDS | Jul 27, 2021 | Pending |
Array
(
[id] => 18642375
[patent_doc_number] => 11766428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Topical amlodipine salts for the treatment of anorectal diseases
[patent_app_type] => utility
[patent_app_number] => 17/305916
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9139
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305916
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/305916 | Topical amlodipine salts for the treatment of anorectal diseases | Jul 15, 2021 | Issued |
Array
(
[id] => 17198725
[patent_doc_number] => 20210338819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => METHOD OF ADMINISTERING LOCAL ANESTHETIC SOLUTION FOR DENTAL AND/OR CONTRAST MEDIA USE
[patent_app_type] => utility
[patent_app_number] => 17/376099
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8353
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17376099
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/376099 | METHOD OF ADMINISTERING LOCAL ANESTHETIC SOLUTION FOR DENTAL AND/OR CONTRAST MEDIA USE | Jul 13, 2021 | Abandoned |
Array
(
[id] => 17290568
[patent_doc_number] => 20210386407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => FUNCTIONALIZED SUPERABSORBENT MATERIAL FOR USE IN LESION PHANTOM
[patent_app_type] => utility
[patent_app_number] => 17/348258
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348258
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/348258 | Functionalized superabsorbent material for use in lesion phantom | Jun 14, 2021 | Issued |
Array
(
[id] => 17110167
[patent_doc_number] => 20210290764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => MEDICAL ITEM FOR PREVENTION AND TREATMENT OF EAR INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/343095
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17343095
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/343095 | MEDICAL ITEM FOR PREVENTION AND TREATMENT OF EAR INFECTION | Jun 8, 2021 | Abandoned |
Array
(
[id] => 17198611
[patent_doc_number] => 20210338705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => ENCAPSULATION AND HIGH ENCAPSULATION EFFICIENCY OF PHOSPHORYLATED ACTIVE AGENTS IN NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/303878
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16444
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17303878
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/303878 | ENCAPSULATION AND HIGH ENCAPSULATION EFFICIENCY OF PHOSPHORYLATED ACTIVE AGENTS IN NANOPARTICLES | Jun 8, 2021 | Abandoned |
Array
(
[id] => 18468732
[patent_doc_number] => 20230203014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => NOVEL FLUORESCENT COMPOUNDS FOR LABELING TUMOR TISSUE
[patent_app_type] => utility
[patent_app_number] => 17/925434
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925434
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/925434 | NOVEL FLUORESCENT COMPOUNDS FOR LABELING TUMOR TISSUE | May 11, 2021 | Pending |
Array
(
[id] => 17052305
[patent_doc_number] => 20210261739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => CATIONIC MUCIC ACID POLYMER-BASED DELIVERY SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/308599
[patent_app_country] => US
[patent_app_date] => 2021-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17308599
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/308599 | CATIONIC MUCIC ACID POLYMER-BASED DELIVERY SYSTEMS | May 4, 2021 | Pending |